The impact of pulse index continuous cardiac output technology on cost/efficiency in ICU. First experience
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
22 0
Căutarea după subiecte
similare conform CZU
616.12-008.31 (32)
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (1025)
SM ISO690:2012
CAMERZAN, Iraida, COZONAC, Gheorghe, GARBUZ, Victor, GUŢU-BAHOV, Cornelia. The impact of pulse index continuous cardiac output technology on cost/efficiency in ICU. First experience. In: Moldovan Medical Journal, 2018, nr. 61(S_AIC), p. 26. ISSN 2537-6373.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 61(S_AIC) / 2018 / ISSN 2537-6373 /ISSNe 2537-6381

The impact of pulse index continuous cardiac output technology on cost/efficiency in ICU. First experience

CZU: 616.12-008.31

Pag. 26-26

Camerzan Iraida1, Cozonac Gheorghe1, Garbuz Victor1, Guţu-Bahov Cornelia12
 
1 St. Trinity Municipal Clinical Hospital,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 23 mai 2024


Rezumat

Background: Currently, the correction guidelines of shocks of different genesis recommend PiCCO monitoring for infusion and vasopressor therapy. Purpose: assessing the impact of PiCCO technology on the cost/effectiveness principle in the ICU. Material and methods: The retrospective study was performed on a group of 125 critical patients divided into two groups, requiring vasopressors, inotropes or infusion therapy, hospitalized during the period 2017-2018 in ICU of the SCM “Sf. Treime”. The treatment was different depending on the reanimatological syndrome. Patients in group I (n = 60) were subjected to PiCCO-guided intensive therapy by measuring dynamic and volumetric parameters, ScvO2, SaO2, MAP, and group II (n = 65) - intensive therapy guided by measuring static parameters (PVC, ScvO2, MAP), with an insignificant difference in age and sex. Results: According to the study data, patients in group I received a higher APACHE II at hospitalization in ICU (lot I (APACHE 26, ISS 14) versus lot II (APACHE 24 p, ISS score 13), and at the end of the treatment – reduction of the hospitalization time in ICU (lot I (5.4 days) versus lot II (7.8 days) but with insignificant influence on the death rate. At the same time, it was noted a reduction in lethality in patients with ketoacidosis (lot I (14.28%) versus lot II (27.27%) in patients with IRA (lot I (0%) versus lot II (16.66%). Conclusions: Guided intensive therapy with PiCCO technology showed a 2.4 days/bed reduction, which implies lower costs ICU, but with an insignificant impact on lethality rates, especially in cardiogenic shock, septic shock, ARDS (Phase III). At the same time, there was a reduction of lethality in cases of ketoacidosis and IRA.

Cuvinte-cheie
PiCCO technique, cost / efficiency, lethality

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-204540</doi_batch_id>
<timestamp>1719636908</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>[email protected]</email_address>
</depositor>
<registrant>Asociaţia Stiinţifică Medicală din Modova</registrant>
</head>
<body>
<journal>
<journal_metadata>
<full_title>Moldovan Medical Journal</full_title>
<issn media_type='print'>25376373</issn>
</journal_metadata>
<journal_issue>
<publication_date media_type='print'>
<year>2018</year>
</publication_date>
<issue>61(S_AIC)</issue>
</journal_issue>
<journal_article publication_type='full_text'><titles>
<title>The impact of pulse index continuous cardiac output technology on cost/efficiency in ICU. First experience</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Iraida</given_name>
<surname>Camerzan</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Gheorghe</given_name>
<surname>Cozonac</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Victor</given_name>
<surname>Garbuz</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Cornelia</given_name>
<surname>Guţu-Bahov</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2018</year>
</publication_date>
<pages>
<first_page>26</first_page>
<last_page>26</last_page>
</pages>
</journal_article>
</journal>
</body>
</doi_batch>